<DOC>
	<DOCNO>NCT03017183</DOCNO>
	<brief_summary>Study participant select clinical routine patient endobronchial infiltration central lung cancer indication bronchoscopic sample . Consented patient undergo bronchoscopy tumor sample apply two routine sample method one single procedure ( EBUS-TBNA conventional forceps sample ) . The sequence sample method randomize advance . The result tissue sample analyze pathologist use multiplex PCR FISH . The corresponding analysis result compare sampling method . Assignment subject particular therapeutic strategy influence protocol . Medicinal product use accord current practice marketing authorisation .</brief_summary>
	<brief_title>Detection Heterogeneity Central Lung Cancer - EBUS-TBNA ctDNA Analysis vs. Endobronchial Forceps Biopsy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Subjects eligible enrolment study must meet following criterion : 1 . Informed consent : sign date write informed consent prior study participation . 2 . Type subject : inpatient 3 . Age : subject 18 year less 85 year . 4 . Central lesion compute tomography highly suspicious lung cancer clinical indication diagnostic applying bronchoscopy . 5 . Central lesion accessible biopsy technique investigation Exclusion criterion : Subjects meet follow criterion must enrol study : 1 . Females pregnant lactating , decide undergo bronchoscopy due risk child 2 . Any contraindication bronchoscopy EBUSTBNA ( IBNLT : INR &gt; 2 , thrombocytopenia &lt; 40/nl ) 3 . Drug/alcohol abuse impair cognitive knowledge need GCP conform inform consent . 4 . Inability read inability language : opinion investigator , subject unable read and/or would able complete study related material .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>